SCHEMBL3228071

SCHEMBL3228071

NC(=O)C(CCCCC(=O)Nc1nc(-c2ccc(N3CCOCC3)cc2)cs1)c1ccc(F)cc1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 8/20 0.47
HDAC6 Q9UBN7 6/20 0.47
HDAC9 Q9UKV0 5/20 0.47
MMP2 P08253 1/20 0.47
MMP8 P22894 1/20 0.47
LMNA P02545 2/20 0.47
MAPK1 P28482 2/20 0.47
CYP1A1 P04798 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP1B1 Q16678 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
KMT2A Q03164 3/20 0.44
POLB P06746 1/20 0.42
ALOX5 P09917 1/20 0.42
HDAC3 O15379 5/20 0.41
HDAC2 Q92769 5/20 0.41
HDAC10 Q969S8 5/20 0.41
HDAC8 Q9BY41 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3228076 0.85 HDAC3 (0.55) HDAC1HDAC6HDAC9MMP2MMP8
SCHEMBL22500344 0.76 KMT2A (0.58) HDAC1HDAC6HDAC9MMP2MMP8
SCHEMBL3235296 0.72 HDAC1 (0.70) HDAC1HDAC6HDAC9LMNAMAPK1
SCHEMBL22501268 0.72 KMT2A (0.62) MMP2MMP8LMNAMAPK1CYP1A1
SCHEMBL3262051 0.71 CYP1A2 (0.43) LMNAMAPK1CYP1A1CYP1A2CYP1B1
SCHEMBL21484812 0.69 KMT2A (0.63) MMP2MMP8LMNAMAPK1CYP1A1
SCHEMBL3238636 0.69 HDAC3 (0.36) HDAC1HDAC6SMN1; SMN2HDAC3HDAC8
SCHEMBL3238723 0.69 HDAC1 (0.61) HDAC1HDAC6HDAC9LMNAMAPK1
SCHEMBL3235060 0.69 KDM4E (0.38) HDAC1SMN1; SMN2POLBHDAC3NPC1
SCHEMBL3235100 0.68 HDAC3 (0.62) HDAC1SMN1; SMN2HDAC3HDAC2HDAC10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010028193-A1 COMPOUNDS INCLUDING PIMELIC ACID DERIVATIVES AS HDAC INHIBITORS REPLIGEN CORPORATION (US) 2010-03-11 WO claimed